Wearing masks helps us keep each other safe. Masks are required in our facilities.
If you cannot wear a mask, contact your care team before you visit to discuss telehealth. Patients and visitors not wearing masks will not be permitted to enter.
A one-year, $500,000 grant from the National Cancer Institute (NCI) will bring more clinical trial opportunities to cancer patients living in Kansas.
Elizabeth Calhoun, PhD, MEd, has been named professor in the department of Population Health and associate dean for population health at the University of Kansas Medical Center.
The University of Kansas Cancer Center’s status as a community site of the National Cancer Institute’s Community Oncology Research Program (NCORP) has been renewed following a successful first year.
Ganguly has been named the A. Drue Jennings Professor in Medical Oncology.
A unique partnership between a researcher usually focused on cancer and a researcher usually focused on cystic fibrosis has resulted in an investigator-initiated clinical trial.
Rosemary, a fragrant herb frequently used in recipes and perfumes, may contain properties that prevent breast cancer from progressing.
Stefan Bossmann, PhD, has joined KU Cancer Center as a member of the Drug Discovery, Delivery and Experimental Therapeutics research program.
Kansas City, Kan. ― The University of Kansas Health System now offers radioembolization, also known as Y-90, as an outpatient procedure at The University of Kansas Hospital in Overland Park. Our fellowship-trained interventional radiologists speciali...
U.S. News & World Report released its 2020-21 Best Hospitals rankings on July 28. The cancer program at The University of Kansas Hospital is recognized among the top 10% of all hospitals in the nation. U.S. News evaluates hospitals on a series of a...
Honor recognizes exceptional service to the field of radiation oncology and cancer care
Graduate student Matthew Schaich forges ahead with research efforts, career aspirations, despite added challenges of pandemic.
The meeting featured a variety of sessions including a Clinical Plenary session, led by Weijing Sun, MD, director of Medical Oncology.
Task force is guided by strategic priorities, include addressing areas of unmet clinical need, unanswered clinical questions and potential new approaches to disease treatment.
More than 42,750 people from 138 countries attended this year’s American Society of Clinical Oncology (ASCO) annual meeting. Held virtually for the first time ever, the meeting featured 2,600 faculty and speakers and 5,300 abstracts delivering the latest news in cancer research. Members of The University of Kansas Cancer Center discussed their key findings and presented dozens of abstracts.
A tiny tool developed by researchers could help detect and track the spread of tumors in breast cancer patients.